Ocular Coulomb Controlled Iontophoresis (OCCI)

I. Nose, Jean-Marie A Parel, W. Lee, F. Cohen, Y. DeKosac, C. Rowaan, A. Paldano, V. Jallet, P. Söderberg, Janet L Davis

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Purpose. Develop and test an ocular drug transfer system (OCCI) based on Coulomb's laws to obtain reliable intraocular drug concentration in a short time while avoiding tissue damage. Methods. A programmable 3 microcomputer chips electronic system was designed to produce an equipotential electrical field with a continuously monitored adjustable constant direct current source connected to 2 electrodes. The active ocular electrode has a constant liquid surface and a drug reservoir connected to 2 syringes containing the drug solution and a partial vacuum. A very low impedance return electrode is used. Transcorneal, transscleral and transcorneoscleral OCCIs were made for experimentation in rabbits and rats. The drug solutions were modified for optimal iontophoretic transfer. Results. No extra- or intraocular tissues damage was detected clinically or by light microscopy. A ≥0.08C/cm2 transcorneal transfer of pimaricin produced 3 MMC in 4min. A ≥500μg/ml Di-hematoporphyrinether intracorneal concentration was obtained for PDT treatment of acanthamoeba infections. Higher intravitreal concentration of fluorescein and dexamethasone were obtained. Conclusion. This pilot study demonstrates OCCI's safety and effectiveness with 4 drugs. Ganciclovir and other drugs are under study. Pharmacokinetics and TEM analyses and extended in vivo studies are necessary before using OCCI in clinical trials.

Original languageEnglish
JournalInvestigative Ophthalmology and Visual Science
Volume37
Issue number3
StatePublished - Feb 15 1996

Fingerprint

Iontophoresis
Pharmaceutical Preparations
Electrodes
Natamycin
Acanthamoeba
Ganciclovir
Syringes
Microcomputers
Vacuum
Fluorescein
Electric Impedance
Dexamethasone
Microscopy
Pharmacokinetics
Clinical Trials
Rabbits
Safety
Light
Infection

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Ocular Coulomb Controlled Iontophoresis (OCCI). / Nose, I.; Parel, Jean-Marie A; Lee, W.; Cohen, F.; DeKosac, Y.; Rowaan, C.; Paldano, A.; Jallet, V.; Söderberg, P.; Davis, Janet L.

In: Investigative Ophthalmology and Visual Science, Vol. 37, No. 3, 15.02.1996.

Research output: Contribution to journalArticle

Nose, I, Parel, J-MA, Lee, W, Cohen, F, DeKosac, Y, Rowaan, C, Paldano, A, Jallet, V, Söderberg, P & Davis, JL 1996, 'Ocular Coulomb Controlled Iontophoresis (OCCI)', Investigative Ophthalmology and Visual Science, vol. 37, no. 3.
Nose I, Parel J-MA, Lee W, Cohen F, DeKosac Y, Rowaan C et al. Ocular Coulomb Controlled Iontophoresis (OCCI). Investigative Ophthalmology and Visual Science. 1996 Feb 15;37(3).
Nose, I. ; Parel, Jean-Marie A ; Lee, W. ; Cohen, F. ; DeKosac, Y. ; Rowaan, C. ; Paldano, A. ; Jallet, V. ; Söderberg, P. ; Davis, Janet L. / Ocular Coulomb Controlled Iontophoresis (OCCI). In: Investigative Ophthalmology and Visual Science. 1996 ; Vol. 37, No. 3.
@article{d6b3fb021b40473c9729b5125630872f,
title = "Ocular Coulomb Controlled Iontophoresis (OCCI)",
abstract = "Purpose. Develop and test an ocular drug transfer system (OCCI) based on Coulomb's laws to obtain reliable intraocular drug concentration in a short time while avoiding tissue damage. Methods. A programmable 3 microcomputer chips electronic system was designed to produce an equipotential electrical field with a continuously monitored adjustable constant direct current source connected to 2 electrodes. The active ocular electrode has a constant liquid surface and a drug reservoir connected to 2 syringes containing the drug solution and a partial vacuum. A very low impedance return electrode is used. Transcorneal, transscleral and transcorneoscleral OCCIs were made for experimentation in rabbits and rats. The drug solutions were modified for optimal iontophoretic transfer. Results. No extra- or intraocular tissues damage was detected clinically or by light microscopy. A ≥0.08C/cm2 transcorneal transfer of pimaricin produced 3 MMC in 4min. A ≥500μg/ml Di-hematoporphyrinether intracorneal concentration was obtained for PDT treatment of acanthamoeba infections. Higher intravitreal concentration of fluorescein and dexamethasone were obtained. Conclusion. This pilot study demonstrates OCCI's safety and effectiveness with 4 drugs. Ganciclovir and other drugs are under study. Pharmacokinetics and TEM analyses and extended in vivo studies are necessary before using OCCI in clinical trials.",
author = "I. Nose and Parel, {Jean-Marie A} and W. Lee and F. Cohen and Y. DeKosac and C. Rowaan and A. Paldano and V. Jallet and P. S{\"o}derberg and Davis, {Janet L}",
year = "1996",
month = "2",
day = "15",
language = "English",
volume = "37",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "3",

}

TY - JOUR

T1 - Ocular Coulomb Controlled Iontophoresis (OCCI)

AU - Nose, I.

AU - Parel, Jean-Marie A

AU - Lee, W.

AU - Cohen, F.

AU - DeKosac, Y.

AU - Rowaan, C.

AU - Paldano, A.

AU - Jallet, V.

AU - Söderberg, P.

AU - Davis, Janet L

PY - 1996/2/15

Y1 - 1996/2/15

N2 - Purpose. Develop and test an ocular drug transfer system (OCCI) based on Coulomb's laws to obtain reliable intraocular drug concentration in a short time while avoiding tissue damage. Methods. A programmable 3 microcomputer chips electronic system was designed to produce an equipotential electrical field with a continuously monitored adjustable constant direct current source connected to 2 electrodes. The active ocular electrode has a constant liquid surface and a drug reservoir connected to 2 syringes containing the drug solution and a partial vacuum. A very low impedance return electrode is used. Transcorneal, transscleral and transcorneoscleral OCCIs were made for experimentation in rabbits and rats. The drug solutions were modified for optimal iontophoretic transfer. Results. No extra- or intraocular tissues damage was detected clinically or by light microscopy. A ≥0.08C/cm2 transcorneal transfer of pimaricin produced 3 MMC in 4min. A ≥500μg/ml Di-hematoporphyrinether intracorneal concentration was obtained for PDT treatment of acanthamoeba infections. Higher intravitreal concentration of fluorescein and dexamethasone were obtained. Conclusion. This pilot study demonstrates OCCI's safety and effectiveness with 4 drugs. Ganciclovir and other drugs are under study. Pharmacokinetics and TEM analyses and extended in vivo studies are necessary before using OCCI in clinical trials.

AB - Purpose. Develop and test an ocular drug transfer system (OCCI) based on Coulomb's laws to obtain reliable intraocular drug concentration in a short time while avoiding tissue damage. Methods. A programmable 3 microcomputer chips electronic system was designed to produce an equipotential electrical field with a continuously monitored adjustable constant direct current source connected to 2 electrodes. The active ocular electrode has a constant liquid surface and a drug reservoir connected to 2 syringes containing the drug solution and a partial vacuum. A very low impedance return electrode is used. Transcorneal, transscleral and transcorneoscleral OCCIs were made for experimentation in rabbits and rats. The drug solutions were modified for optimal iontophoretic transfer. Results. No extra- or intraocular tissues damage was detected clinically or by light microscopy. A ≥0.08C/cm2 transcorneal transfer of pimaricin produced 3 MMC in 4min. A ≥500μg/ml Di-hematoporphyrinether intracorneal concentration was obtained for PDT treatment of acanthamoeba infections. Higher intravitreal concentration of fluorescein and dexamethasone were obtained. Conclusion. This pilot study demonstrates OCCI's safety and effectiveness with 4 drugs. Ganciclovir and other drugs are under study. Pharmacokinetics and TEM analyses and extended in vivo studies are necessary before using OCCI in clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=24844451248&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24844451248&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:24844451248

VL - 37

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 3

ER -